Comparison of the serum metabolic signatures based on 1H NMR between patients and a rat model of deep vein thrombosis.
Ontology highlight
ABSTRACT: Deep vein thrombosis (DVT) and pulmonary embolism (PE) have high morbidity, reduce quality of life, and can cause death. Biomarkers or genetic risk factors have not been identified in patients with DVT. In present study, serum of 61 patients suffering from DVT and a rat DVT model (n = 10) were assayed by a proton nuclear magnetic resonance (1H NMR) metabolomics technique combing with multivariate statistical analysis to identify the metabolites. The MetPA platform was used to identify differences in the metabolic pathways between the rat model and patients. The metabolomics results discovered that 11 different metabolites in rats and 20 different metabolites in DVT patients. Seven metabolites both altered in the rats and patients. Moreover, we observed changes in the metabolic pathways, in
SUBMITTER: Cao J
PROVIDER: S-EPMC5959905 | biostudies-literature | 2018 May
REPOSITORIES: biostudies-literature
ACCESS DATA